Suppr超能文献

体重指数是否“稀释”了前列腺特异性抗原对根治性前列腺切除术中肿瘤体积的预测作用?

Does body mass index "dilute" the predictive property of prostate-specific antigen for tumor volume at radical prostatectomy?

机构信息

Department of Urology, Mayo Clinic, Rochester, MN, USA.

出版信息

Urology. 2011 Oct;78(4):868-72. doi: 10.1016/j.urology.2011.05.060. Epub 2011 Aug 16.

Abstract

OBJECTIVE

To evaluate the effect of the body mass index (BMI) as it relates to the predictive value of the preoperative prostate-specific antigen (PSA) level regarding the tumor volume at radical prostatectomy. Stage migration with the widespread use of PSA screening is well documented; however, the association between the PSA level and tumor volume is less defined. Additionally, the effect of obesity on the serum PSA level might cause relative hemodilution and account for the decreased predictive ability of the PSA level to determine the tumor volume in the modern era.

METHODS

We identified 14 293 patients who had undergone radical prostatectomy for prostate cancer from 1987 to 2007 and had a documented BMI. Using the clinicopathologic variables, we examined the relationship among the BMI, preoperative PSA level, and tumor volume at radical prostatectomy using multiple linear regression analysis.

RESULTS

An elevated BMI was associated with an increased pathologic Gleason score (P < .0001), increased tumor volume (P < .0001), and increased prostate size (P < .0001). The preoperative PSA level correlated significantly with the tumor volume (P < .0001). No significant correlation was found between the BMI and preoperative PSA level (P = .39). On multivariate analysis, controlling for the BMI, the preoperative PSA level remained a significant predictor of the tumor volume (P < .0001). The interaction between the preoperative PSA level and BMI in the prediction of the tumor volume was not statistically significant (P = .56), suggesting that the BMI does not affect the association between the PSA level and tumor volume.

CONCLUSION

Our results have shown that the predictive ability of the PSA level for tumor volume is not affected by the BMI. There does not appear to be a need to correct the serum PSA level in relation to the BMI when used in preoperative prediction models of the tumor volume.

摘要

目的

评估体重指数(BMI)与术前前列腺特异性抗原(PSA)水平对根治性前列腺切除术时肿瘤体积的预测价值之间的关系。广泛应用 PSA 筛查导致了疾病分期迁移,这一点已有充分的文献记载;然而,PSA 水平与肿瘤体积之间的关联则不太明确。此外,肥胖对血清 PSA 水平的影响可能导致相对血液稀释,从而降低 PSA 水平在现代确定肿瘤体积的预测能力。

方法

我们从 1987 年至 2007 年确定了 14293 例接受根治性前列腺切除术治疗前列腺癌且有记录的 BMI 的患者。我们使用临床病理变量,通过多元线性回归分析,检查了 BMI、术前 PSA 水平和根治性前列腺切除术中肿瘤体积之间的关系。

结果

BMI 升高与病理 Gleason 评分升高(P<0.0001)、肿瘤体积增大(P<0.0001)和前列腺增大(P<0.0001)相关。术前 PSA 水平与肿瘤体积显著相关(P<0.0001)。BMI 与术前 PSA 水平之间无显著相关性(P=0.39)。多元分析中,控制 BMI 后,术前 PSA 水平仍然是肿瘤体积的重要预测因素(P<0.0001)。术前 PSA 水平和 BMI 对肿瘤体积的预测之间的相互作用无统计学意义(P=0.56),这表明 BMI 并不影响 PSA 水平与肿瘤体积之间的关系。

结论

我们的结果表明,PSA 水平对肿瘤体积的预测能力不受 BMI 的影响。在使用肿瘤体积的术前预测模型时,似乎没有必要根据 BMI 来校正血清 PSA 水平。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验